polo kinase

1 stories · following the connections

Business

Cyclacel’s Novel PLK1 Inhibitor, CYC140, Demonstrates Therapeutic Potential in Esophageal Cancer and Acute Leukemia

By Nasdaq OMXDec 1, 2016, 12:00 PM UTC